Supplemental material
Report
Modifying antibody-FcRn interactions to increase the transport of antibodies through the blood-brain barrier
Jason Tiena Biologics Discovery Science, Teva Pharmaceutical Industries Ltd, Redwood City, CA, USACorrespondence[email protected]
https://orcid.org/0000-0003-3853-0827
https://orcid.org/0000-0003-3853-0827, , Ralitsa Petrovaa Biologics Discovery Science, Teva Pharmaceutical Industries Ltd, Redwood City, CA, USAhttps://orcid.org/0000-0001-5586-6192
https://orcid.org/0000-0001-5586-6192, , , , , , , , , Hussein Hallakb Non Clinical Development, Teva Pharmaceutical Industries, Netanya, Israelhttps://orcid.org/0000-0002-1685-1374
https://orcid.org/0000-0002-1685-1374, & show all